Press Releases
Page 10 • 12 itemsAccess critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Perceptive Discovery Partners with MH3D to Launch α-Sight™ Alpha Radiopharmaceutical Imaging Platform
Perceptive Discovery announces strategic partnership with MH3D and launches α-Sight™ preclinical imaging platform for alpha-emitting radiopharmaceuticals in oncology.
P&G Health Launches First APAC Pharmacist Guidelines for Peripheral Neuropathy Management
P&G Health and APAC experts release region's first community pharmacist guidelines for peripheral neuropathy, affecting 1 in 2 diabetics and 1 in 10 adults.
Corcept Therapeutics Faces FDA Rejection of Relacorilant for Cushing's Syndrome, Investor Lawsuit Filed
Corcept Therapeutics received FDA Complete Response Letter rejecting relacorilant for Cushing's syndrome due to insufficient evidence, sparking investor lawsuit.
Florida Cancer Specialists & Research Institute Advances Medically Integrated Oncology Care Model
Florida Cancer Specialists & Research Institute showcases leadership in medically integrated oncology care, improving patient outcomes through innovative treatment models.
Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System
Phantom Neuro gets approval for first-in-human trial of Phantom X neural interface system in Australia, marking major milestone for prosthetic control technology.
Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and Drug-Resistant Cancers in Preclinical Studies
Phrontline Biopharma presents preclinical data for TJ106, a biparatopic HER2 ADC showing activity in HER2-low and resistant tumors at AACR 2026.
XellSmart Advances XS411 Parkinson's Cell Therapy to Phase II Trial After Positive Phase I Results
XellSmart launches multicenter Phase II trial for XS411, an iPSC-derived dopaminergic cell therapy for Parkinson's disease following encouraging Phase I data.
Peer AI Launches Advanced Regulatory Platform with Predictive Intelligence for Life Sciences Submissions
Peer AI expands its agentic AI platform for life sciences with real-time visibility and predictive regulatory query capabilities to streamline drug submissions.
WuXi Biologics Achieves ISO 13485 Certification for Drug-Device Combination Products Manufacturing
WuXi Biologics becomes first in China to achieve ISO 13485:2016 certification with zero non-conformities for drug-device combination product development.
Atelerix Partners with JH Health to Expand Non-Cryogenic Cell Preservation Technology in Middle East
Atelerix forms strategic partnership with JH Health Ltd to bring revolutionary hydrogel cell preservation technology to Saudi Arabia and Middle East markets.
Chitosan Market Surges 14.3% CAGR as KitoZyme, Primex Lead $7.6B Pharmaceutical Biopolymer Boom by 2036
Global chitosan market projected to reach $7.61 billion by 2036 with 14.3% CAGR, driven by pharmaceutical, cosmetic, and nutraceutical applications.
Telix Pharmaceuticals Doses First Patient in Phase 3 Trial of TLX101-Tx for Recurrent Glioblastoma
Telix begins Phase 3 IPAX-BrIGHT trial of TLX101-Tx, marking the first radiopharmaceutical therapy to reach Phase 3 for recurrent glioblastoma treatment.